+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 23Years - 65Years
All Genders
ID07433998

Study on Daily Ginger-Enriched Beverage Effects on Inflammation, Oxidative Stress, and Heart Health in Adults with Excess Weight

Led by Javier Marhuenda · Updated on 2026-03-04

50

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are evaluating the daily consumption of a ginger-based beverage and its effects on inflammation, oxidative stress, and endothelial damage in adults with excess body fat. This randomized, double-blind, placebo-controlled clinical trial aims to better understand how ginger may influence markers related to cardiometabolic risk factors in adults aged 23 to 65 without diagnosed chronic diseases. Participants will be randomly assigned to consume either a functional beverage enriched with ginger or a matched placebo beverage daily for 60 days. Both study groups will follow this regimen under a double-blind design, ensuring neither participants nor researchers know who receives the ginger-enriched drink or placebo during the trial. During the 60-day study, participants will be assessed for changes in blood levels of inflammatory markers, oxidative stress indicators, and cardiovascular risk factors including cholesterol, blood pressure, body weight, and body composition. These measurements will be taken at the start and end of the trial to monitor the effects of the intervention. Participants will be asked to comply with study procedures and attend scheduled visits for evaluations.

CONDITIONS

Brief Title

Effect of a Ginger-Based Beverage on Inflammation, Oxidative Stress, and Endothelial Function

Research Team

J

Javier Marhuenda Hernández

U

Universidad Católica San Antonio de Murcia

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here